CompletedPhase 3NCT00369317
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Studying Down syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Jeffrey Taub, MDChildren's Oncology Group
- Intervention
- asparaginase(drug)
- Enrollment
- 205 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2007 – 2021
Study locations (30)
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- Southern California Permanente Medical Group, Downey, California, United States
- Miller Children's Hospital, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Children's Hospital Central California, Madera, California, United States
- Children's Hospital and Research Center at Oakland, Oakland, California, United States
- Kaiser Permanente-Oakland, Oakland, California, United States
- Childrens Hospital of Orange County, Orange, California, United States
- Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
- Rady Children's Hospital - San Diego, San Diego, California, United States
- University of California San Francisco Medical Center-Parnassus, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Lombardi Comprehensive Cancer Center at Georgetown University, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00369317 on ClinicalTrials.govOther trials for Down syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07416201Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without ThymectomyNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT07484464Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down SyndromeRiphah International University
- RECRUITINGNCT07195253Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down SyndromeHospices Civils de Lyon
- RECRUITINGNANCT07296861HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down SyndromeUNC Lineberger Comprehensive Cancer Center
- ENROLLING BY INVITATIONNCT07413224Qualitative Effects of AEF0217 in Down Syndrome PeopleAelis Farma
- RECRUITINGNANCT07425769Adapting RDAD for DSUniversity of Kansas Medical Center
- RECRUITINGPHASE4NCT07280468Endotype DIrected Treatment for OSA in Down SyndromeUniversity of Arizona
- RECRUITINGPHASE2NCT07242638Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeIcahn School of Medicine at Mount Sinai